As of 3:59pm ET
| +0.26 / +0.40%|
Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from biological processes called biologics. The company's biopharmaceutical research and development efforts in the affective (psychiatric) disorders, Alzheimer's/dementia, cardiovascular, diabetes, hepatitis, HIV/Acquired Immunodeficiency Syndrome (AIDS), oncology, immunologic disorders and fibrotic disease areas. Bristol-Myers Squibb was founded in August 1933 and is headquartered in New York, NY.
|Lamberto Andreotti||Chief Executive Officer & Director|
|Giovanni Caforio||President, CEO-Designate, COO & Director|
|Charles A. Bancroft||Chief Financial Officer & Executive Vice President|
|Paul von Autenried||Chief Information Officer & Senior Vice President|
|Francis M. Cuss||Chief Scientific Officer & Executive VP|